62913-9 |
PhenX - acculturation protocol 180101 |
- |
^Patient |
Pt |
- |
PhenX |
|
TRIAL |
PhenX - acculturation protocol 180101 |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
62913-9 |
|
PhenX |
|
|
|
|
|
|
0 |
Acculturation proto |
|
PX180101 |
|
N |
|
Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.66 |
2.36 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
62914-7 |
PhenX measure - coping styles |
- |
^Patient |
Pt |
- |
PhenX |
|
DEPRECATED |
Deprecated PhenX measure - coping styles |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
62914-7 |
|
PhenX |
|
|
|
|
|
|
0 |
|
|
PhenX.180200 |
|
N |
|
Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.46 |
2.36 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
62916-2 |
PhenX - coping styles - adult protocol 180202 |
- |
^Patient |
Pt |
- |
PhenX |
|
TRIAL |
PhenX - coping styles - adult protocol 180202 |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
62916-2 |
|
PhenX |
|
|
|
|
|
|
0 |
Coping styles adult proto |
|
PX180202 |
|
N |
|
Coping styles adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.66 |
2.36 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
61417-2 |
Imipramine/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Imipramine/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/g creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
61417-2 |
|
|
|
|
Both |
|
|
|
0 |
Imipramine/Creat Ur |
|
|
|
N |
|
CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Imipra; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Tofranil; UA; UCr; UR; Urn |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/g{creat} |
|
|
|
0 |
61420-6 |
Norhydrocodone/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Norhydrocodone/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/g creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
61420-6 |
|
|
|
|
Both |
|
|
|
0 |
Norhydrocodone/Creat Ur |
|
|
|
N |
|
CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Hydrocodone metabolite; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/g{creat} |
|
|
|
0 |
61423-0 |
Noroxycodone/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Noroxycodone/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/g creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
61423-0 |
|
|
|
|
Both |
|
|
|
0 |
Noroxycodone/Creat Ur |
|
|
|
N |
|
CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/g{creat} |
|
|
|
0 |
61426-3 |
Nortriptyline/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Nortriptyline/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/g creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
61426-3 |
|
|
|
|
Both |
|
|
|
0 |
Nortrip/Creat Ur |
|
|
|
N |
|
Amitriptyline metabolite; Aventyl; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Nortrip; Nortriptylene; Nortriptyln; Pamelor; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/g{creat} |
|
|
|
0 |
61429-7 |
Tapentadol/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Tapentadol/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/g creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
61429-7 |
|
|
|
|
Both |
|
|
|
0 |
Tapentadol/Creat Ur |
|
|
|
N |
|
CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Nucynta; Palexia; Point in time; QNT; Quan; Quant; Quantitative; Random; Tapal; UA; UCr; UR; Urn |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/g{creat} |
|
|
|
0 |
62201-9 |
XXX microorganism DNA |
Prid |
Ser/Plas |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
XXX microorganism DNA [Identifier] in Serum or Plasma by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
62201-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Other microorg DNA SerPl NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Microorganisms; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Org; Organism; Organisms; Other microorg; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.63 |
2.38 |
|
|
|
|
|
|
|
|
|
|
|
0 |
62202-7 |
XXX microorganism DNA |
Prid |
Isolate |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
XXX microorganism DNA [Identifier] in Isolate by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
62202-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Other microorg DNA Islt NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Microorganisms; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Org; Organism; Organisms; Other microorg; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.63 |
2.38 |
|
|
|
|
|
|
|
|
|
|
|
0 |
102065-0 |
Perfluorohexane sulfonate |
MCnc |
Ser/Plas |
Pt |
Qn |
LC/MS/MS |
|
ACTIVE |
Perfluorohexane sulfonate [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
NAM |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
102065-0 |
|
LC/MS/MS |
|
|
Observation |
|
|
|
0 |
PFHxS SerPl LC/MS/MS-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PFHxS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.77 |
2.75 |
|
|
|
|
|
|
|
ng/mL |
|
|
Release 2.77: COMPONENT: updated to the the anionic name ; |
0 |
62670-5 |
PhenX - prostate health protocol 101201 |
- |
^Patient |
Pt |
- |
PhenX |
|
TRIAL |
PhenX - prostate health protocol 101201 |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
62670-5 |
|
PhenX |
|
|
|
|
|
|
0 |
Prostate health proto |
|
PX101201 |
|
N |
|
Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.73 |
2.36 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
62671-3 |
PhenX measure - reproductive history |
- |
^Patient |
Pt |
- |
PhenX |
|
DEPRECATED |
Deprecated PhenX measure - reproductive history |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
62671-3 |
|
PhenX |
|
|
|
|
|
|
0 |
|
|
PhenX.101300 |
|
N |
|
Hx; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.46 |
2.36 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
62917-0 |
PhenX measure - current quality of life |
- |
^Patient |
Pt |
- |
PhenX |
|
DEPRECATED |
Deprecated PhenX measure - current quality of life |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
62917-0 |
|
PhenX |
|
|
|
|
|
|
0 |
|
|
PhenX.180300 |
|
N |
|
Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.46 |
2.36 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
62918-8 |
PhenX - current quality of life protocol 180301 |
- |
^Patient |
Pt |
- |
PhenX |
|
TRIAL |
PhenX - current quality of life protocol 180301 |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
62918-8 |
|
PhenX |
|
|
|
|
|
|
0 |
Current quality of life proto |
|
PX180301 |
|
N |
|
Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.66 |
2.36 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
63112-7 |
Rubus fruticosus Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Blackberry IgG Ab [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
Numeric |
|
|
|
|
|
ALLERGY |
|
63112-7 |
|
|
|
|
Both |
|
|
|
0 |
Blackberry IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blackberry; f022; f211; f22; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf211; Serum; SR |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
63113-5 |
Rabbit Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Rabbit IgG Ab [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
Numeric |
|
|
|
|
|
ALLERGY |
|
63113-5 |
|
|
|
|
Both |
|
|
|
0 |
Rabbit IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f213; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Oryctalagus spp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
63114-3 |
Capsicum annuum Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Paprika IgG Ab [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
Numeric |
|
|
|
|
|
ALLERGY |
|
63114-3 |
|
|
|
|
Both |
|
|
|
0 |
Paprika IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f218; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Paprika; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet pepper |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
63115-0 |
Papaver somniferum Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Poppy Seed IgG Ab [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
Numeric |
|
|
|
|
|
ALLERGY |
|
63115-0 |
|
|
|
|
Both |
|
|
|
0 |
Poppy Seed IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f224; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; Poppy seed; QNT; Quan; Quant; Quantitative; Random; Rf224; Serum; SR |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
63116-8 |
Cucurbita pepo Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Pumpkin IgG Ab [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
Numeric |
|
|
|
|
|
ALLERGY |
|
63116-8 |
|
|
|
|
Both |
|
|
|
0 |
Pumpkin IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C. maxima; C. mixta; C. moschata; Cucumis pepo; f225; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; Pumpkin; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
63124-2 |
Ocimum basilicum Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Basil IgG Ab [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
Numeric |
|
|
|
|
|
ALLERGY |
|
63124-2 |
|
|
|
|
Both |
|
|
|
0 |
Basil IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Basil; f269; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf269; Serum; SR |
2.73 |
2.36 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
57795-7 |
Fecal hydrolysis panel |
- |
Stool |
Pt |
- |
|
|
ACTIVE |
Fecal hydrolysis panel - Stool |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
57795-7 |
|
|
|
|
Order |
|
|
|
0 |
Fecal hydrolysis pnl Stl |
|
|
|
N |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Fecal hydrolysis pnl; Feces; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Stl; Stool = Fecal |
2.42 |
2.36 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
57593-6 |
Aldosterone^30M pre XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Aldosterone [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
57593-6 |
|
|
|
|
Observation |
|
|
|
0 |
Aldost 30M pre chal SerPl-mCnc |
|
|
|
N |
|
30M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.36 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
57594-4 |
Aldosterone^30M pre XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Aldosterone [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
57594-4 |
|
|
|
|
Observation |
|
|
|
0 |
Aldost 30M pre chal SerPl-sCnc |
|
|
|
N |
|
30M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.36 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
57645-4 |
C peptide^10M pre XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Moles/volume] in Serum or Plasma --10 minutes pre XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
57645-4 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 10M pre chal SerPl-sCnc |
|
|
|
N |
|
10M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Pept; Pl; Plasma; Plsm; Point in time; pre chal; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.36 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |